Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114031543A reveals a convergent 3-step synthesis for PF-07321332 intermediate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of 16β-methyl steroid intermediates via novel dehydration and epoxidation. Cost-effective route for Betamethasone precursors ensuring high purity.
Patent CN115124444B details a waste-free synthesis route for Florfenicol intermediates offering significant supply chain and cost advantages for global buyers.
Novel synthesis method for dyclonine hydrochloride ensures high purity and yield. Cost-effective manufacturing process for reliable pharmaceutical intermediate supply chain partners.
Patent CN101648839A details a sunlight-driven bromination process for biphenyl compounds, offering a safer, greener route for pharmaceutical intermediate manufacturing with enhanced purity.
Novel solvent crystallization method removes dimer impurities, ensuring >99.5% purity for schizophrenia treatment APIs.
Patent CN114591217A reveals a novel lactone-based route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering superior atom economy and cost reduction in API manufacturing for antiviral drugs.
Novel synthesis route for kinase inhibitor intermediates offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Novel Rh-catalyzed route to fused macrocyclic sulfoximines. High yield, room temp process reduces manufacturing costs and ensures supply continuity for pharma intermediates.
Discover a novel iron-catalyzed synthesis for benzimidazole intermediates. This patent-driven approach offers significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturing.
New patent CN105399736B offers high purity brexpiprazole intermediate synthesis with mild conditions ensuring supply chain reliability and cost reduction for pharmaceutical manufacturing.
Novel synthesis technology for racemic ketoprofen isoleucine calcium ensures high purity and cost efficiency. Reliable supply chain for pharmaceutical intermediates and renal care compounds.
Patent CN106866682A reveals optimized Ticagrelor synthesis yielding 99.6% purity. Discover cost-effective manufacturing solutions for pharmaceutical intermediates.
Novel palladium-catalyzed route offers high stereoselectivity and mild conditions for scalable pharmaceutical intermediate manufacturing with significantly reduced operational costs and enhanced supply chain reliability for global buyers.
Patent CN101456838B details a metal-free chiral phosphoric acid catalyzed route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Novel route for BIBR-953 using 3-nitro-4-chlorobenzoic acid improves yield to 50%, offering cost-effective pharmaceutical intermediates.
Patent CN105063162A reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability in pharmaceutical manufacturing processes.
Novel patent CN121293202A details green racemization and reduction for Finerenone intermediates, offering cost reduction and supply chain reliability for manufacturers.
Patent CN121537464A reveals a streamlined gestodene synthesis route. Achieve 99.7% purity with reduced steps and enhanced supply chain reliability for pharmaceutical intermediates.
Novel protoapigenone derivatives inhibiting GSTO1 activity. Scalable synthesis for anti-cancer drug development. Cost-effective supply chain solutions for global partners.